- IPXL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $18.0 million.
- IPXL has traded 31,202 shares today.
- IPXL is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in IPXL with the Ticky from Trade-Ideas. See the FREE profile for IPXL NOW at Trade-Ideas More details on IPXL: Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products; and develops and markets branded products. The company operates through two segments, Global Pharmaceuticals Division and Impax Pharmaceutical Division. IPXL has a PE ratio of 44.8. Currently there is 1 analyst that rates Impax Laboratories a buy, 1 analyst rates it a sell, and 6 rate it a hold. The average volume for Impax Laboratories has been 581,500 shares per day over the past 30 days. Impax has a market cap of $2.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.73 and a short float of 12% with 12.58 days to cover. Shares are up 20.4% year-to-date as of the close of trading on Wednesday.